My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 320

    1.

    Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.

    Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, Souza LM, Greenberg PL.

    Ann Intern Med. 1989 Jun 15;110(12):976-84.PMID: 2471429 [PubMed - indexed for MEDLINE]Related articles

    2.

    Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.

    Antin JH, Smith BR, Holmes W, Rosenthal DS.

    Blood. 1988 Aug;72(2):705-13.PMID: 3042046 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.

    Greenberg P, Negrin R, Nagler A, Vincent M, Donlon T.

    Int J Cell Cloning. 1990 Jan;8 Suppl 1:293-300; discussion 300-2.PMID: 1691248 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes.

    Yoshida Y, Hirashima K, Asano S, Takaku F.

    Br J Haematol. 1991 Jul;78(3):378-84.PMID: 1714759 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

    Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU.

    N Engl J Med. 1987 Dec 17;317(25):1545-52.PMID: 3500414 [PubMed - indexed for MEDLINE]Related articles

    6.

    Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.

    Thompson JA, Lee DJ, Kidd P, Rubin E, Kaufmann J, Bonnem EM, Fefer A.

    J Clin Oncol. 1989 May;7(5):629-37.PMID: 2651578 [PubMed - indexed for MEDLINE]Related articles

    7.

    Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.

    Glaspy JA, Baldwin GC, Robertson PA, Souza L, Vincent M, Ambersley J, Golde DW.

    Ann Intern Med. 1988 Nov 15;109(10):789-95.PMID: 2461131 [PubMed - indexed for MEDLINE]Related articles

    8.

    Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.

    Ganser A, Völkers B, Greher J, Ottmann OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D.

    Blood. 1989 Jan;73(1):31-7.PMID: 2642714 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes.

    Estey EH, Kurzrock R, Talpaz M, McCredie KB, O'Brien S, Kantarjian HM, Keating MJ, Deisseroth AB, Gutterman JU.

    Br J Haematol. 1991 Mar;77(3):291-5.PMID: 2012752 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report.

    Kobayashi Y, Okabe T, Ozawa K, Chiba S, Hino M, Miyazono K, Urabe A, Takaku F.

    Am J Med. 1989 Feb;86(2):178-82.PMID: 2464280 [PubMed - indexed for MEDLINE]Related articles

    11.

    Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor.

    Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL.

    Blood. 1990 Jul 1;76(1):36-43.PMID: 1694702 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.

    Ganser A, Seipelt G, Verbeek W, Ottmann OG, Maurer A, Kolbe K, Hess U, Elsner S, Reutzel R, Wörmann B, et al.

    Leukemia. 1994 Mar;8(3):369-75.PMID: 7510354 [PubMed - indexed for MEDLINE]Related articles

    13.

    Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.

    Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, Greenberg PL.

    Blood. 1996 May 15;87(10):4076-81.PMID: 8639764 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes.

    Greenberg PL, Negrin R, Nagler A.

    Cancer Surv. 1990;9(1):199-212. Review.PMID: 2276114 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.

    Herrmann F, Lindemann A, Klein H, Lübbert M, Schulz G, Mertelsmann R.

    Leukemia. 1989 May;3(5):335-8.PMID: 2654495 [PubMed - indexed for MEDLINE]Related articles

    16.

    A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes.

    Nand S, Sosman J, Godwin JE, Fisher RI.

    Blood. 1994 Jan 15;83(2):357-60.PMID: 8286736 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.

    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.

    Haematologica. 2001 Jan;86(1):44-51.PMID: 11146570 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.

    Hansen PB, Johnsen HE, Hippe E, Hellström-Lindberg E, Ralfkiaer E.

    Am J Hematol. 1993 Dec;44(4):229-36.PMID: 8237992 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol.

    Ganser A, Maurer A, Contzen C, Seipelt G, Ottmann OG, Schadeck-Gressel C, Kolbe K, Haas R, Zander C, Reutzel R, Hoelzer D.

    Ann Hematol. 1996 Apr;72(4):237-44.PMID: 8624378 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: a multicenter study.

    Chuncharunee S, Intragumtornchai T, Chaimongkol B, Prayoonwiwat W, Leelasiri A, Lekhakula A, Chansung K, Yoshida Y.

    Int J Hematol. 2001 Aug;74(2):144-6.PMID: 11594513 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity